Project scope
To understand how to leverage innovative and generic oncology products portfolio and achieve a higher uptake
Egypt
KSA
UAE
Vietnam
Challenge
Our client has a breadth of innovative and generic oncology drugs and was looking to understand how to leverage their portfolio and achieve higher uptake through a portfolio contracting approach
Solution
Extensive secondary research into core markets and operating mechanisms:
- Primary research consisting of qualitative discussions with payers and oncologists
- Identification of contracting strategies based on the analysis carried out
Results
- Facilitated client understanding of key innovative contracts in oncology through in-depth strategic analysis of Egypt, Morocco, Saudi Arabia and UAE markets
- Prioritization of products to be placed in the oncology portfolio deal
Note: MEA: Middle East and Africa; UAE: United Arab Emirates
